Company: FVN
Filing Date: 2025-04-14
Form Type: DRS/A
Source: 0001829126-25-002616
Chunk: 171

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-04-14
Form: DRS/A
Chunk 171
---
 approval, and he will be able to, subject to applicable law, participate in the election of the members of the Board of Directors and actions to be taken by it, including amendments to the Amended and Restated Memorandum and Articles of Association (assuming it is approved by the Shareholders) and approval of significant corporate transactions, including mergers and sales of substantially all of its assets. The directors so elected will have the authority, subject to applicable rules and regulations, to issue additional share, implement share repurchase programs, declare dividends and make other decisions. It is possible that the interests of this Shareholder may in some circumstances conflict with the Company’s interests and the interests of its other Shareholders. This could influence his decisions, including with regard to whether and when to dispose of assets and whether and when to incur new or refinance existing indebtedness. In addition, the determination of future tax reporting positions, the structuring of future transactions and the handling of any future challenges by any taxing authorities to the Company’s tax reporting positions may take into consideration this Shareholder’s tax or other considerations, which may differ from the Company’s considerations or those of its other Shareholders.

If New VIWO meets the definition of a “controlled company” under the rules of the Nasdaq Listing Rule, it may choose to exempt from certain corporate governance requirements that could have an adverse effect on the public shareholders.

Following consummation of the Business Combination, the VIWO shareholders will beneficially own approximately 54.89% of the combined voting power of New VIWO and VIWO’s majority shareholder, CDDI, will beneficially own approximately 30.19% of the combined voting power of New VIWO ordinary shares. However, assuming the maximum number of redemptions by the Future Vision public shareholders and conversion of public and private rights to 604,900 shares and issuance of 28,750 representative shares as deferred underwriting commission, New VIWO’s majority shareholder would beneficially own 44.21%, and if acting as a group, VIWO shareholders will beneficially own approximately 80.39% of the combined voting power of New VIWO ordinary shares and in such an event, New VIWO would be a “controlled company” as defined in the corporate governance rules of Nasdaq. For so long as New VIWO is as a controlled company under that definition, it would be permitted to elect to rely on certain exemptions from the Nasdaq corporate governance rules, including the requirements that (i) a majority of the board of directors consists